M. N. V. Ravi Kumar (0000-0001-5606-401X)

Personal information

Biography

Dr. M. N. V. Ravi Kumar is a Distinguished University Research Professor and the Founding Director of the Center for Convergent Bioscience and Medicine (CCBM) at The University of Alabama, Tuscaloosa. Prior to his current position, Dr. Kumar served on faculty at the National Institute of Pharmaceutical Education and Research (NIPER), Mohali, India, University of Strathclyde, Glasgow, UK, and Texas A&M University, College Station, Texas, USA. Dr. Kumar has made substantial contributions to advancing the field of nanomedicines, as evidenced by numerous high-impact publications, abstracts/conference presentations, and invited/guest lectures. Dr. Kumar has won several internationally recognized awards and secured a strong extramural, federally funded research program that drives innovative contributions to the future of therapeutic development.

Activities

Collapse all

The University of Alabama: Tuscaloosa, Alabama, US

2021-01-14 to present | Distinguished University Research Professor (Bioscience and Medicine Initiative, College of Community Health Sciences)

Employment

M. N. V. Ravi Kumar

https://orcid.org/0000-0001-5606-401X

Personal information

Emails & domains

Verified email addresses

Verified email domains

Websites & social links

Other IDs

Keywords

Countries

Biography

Activities

Employment (4)

The University of Alabama: Tuscaloosa, Alabama, US

Texas A&M University: College Station, TX, US

University of Strathclyde: Glasgow, Glasgow, GB

National Institute of Pharmaceutical Education and Research: Sas Nagar, Punjab, IN

Education and qualifications (1)

Indian Institute of Technology Roorkee: Roorkee, Uttar Pradesh, IN

Funding (1)

Training the next generation graduate student in lupus research

Works (50 of 87)

UPLC-MS/MS Method for Simultaneous Quantification of Cyclosporine A and Urolithin A in Plasma and Interspecies Analysis Across Mammals Including Humans

Prospects for the convergence of polyphenols with pharmaceutical drugs in type 2 diabetes: Challenges, risks, and strategies

Nanotechnology-Enhanced Naloxone and Alternative Treatments for Opioid Addiction

Polyester Nanoparticles with Controlled Topography for Peroral Drug Delivery Using Insulin as a Model Protein

Chronic Interstitial Nephritis in Agricultural Communities

Leveraging Lymphatic System Targeting in Systemic Lupus Erythematosus for Improved Clinical Outcomes

Rationally Designed Naringenin-Conjugated Polyester Nanoparticles Enable Folate Receptor-Mediated Peroral Delivery of Insulin

Systemic Anti-Inflammatory Therapy Aided by Curcumin-Laden Double-Headed Nanoparticles Combined with Injectable Long-Acting Insulin in a Rodent Model of Diabetes Eye Disease

Nano-encapsulation strategies to circumvent drug-induced kidney injury and targeted nanomedicines to treat kidney diseases

Paclitaxel and Urolithin A Prevent Histamine-Induced Neurovascular Breakdown Alike, in an Ex Vivo Rat Eye Model

Systemic anti-inflammatory therapy aided by double-headed nanoparticles in a canine model of acute intraocular inflammation

Novel Oral Nanoparticle Formulation of Sustained Release Naloxone with Mild Withdrawal Symptoms in Mice

A highly potent lymphatic system–targeting nanoparticle cyclosporine prevents glomerulonephritis in mouse model of lupus

Double-headed nanosystems for oral drug delivery

Next-Generation Noncompetitive Nanosystems Based on Gambogic Acid: In Silico Identification of Transferrin Receptor Binding Sites, Regulatory Shelf Stability, and Their Preliminary Safety in Healthy Rodents

Polyester Nanoparticle Encapsulation Mitigates Paclitaxel-Induced Peripheral Neuropathy

Editorial – Metronomic chemotherapy

Featuring the Guest Editors

Ex Vivo Rat Eye Model for Investigating Transport of Next Generation Precision-Polyester Nanosystems

Nano-curcumin safely prevents streptozotocin-induced inflammation and apoptosis in pancreatic beta cells for effective management of Type 1 diabetes mellitus

Next Generation Precision-Polyesters Enabling Optimization of Ligand–Receptor Stoichiometry for Modular Drug Delivery

Noncompetitive Active Transport Exploiting Intestinal Transferrin Receptors for Oral Delivery of Proteins by Tunable Nanoplatform

Can Controversial Nanotechnology Promise Drug Delivery?

Development and evaluation of polymer nanoparticles for oral delivery of estradiol to rat brain in a model of Alzheimer's pathology

Nanoparticulate Delivery Can Improve Peroral Bioavailability of Cyclosporine and Match Neoral C-max Sparing the Kidney from Damage

Poly(lactide-co-glycolide) nanoparticles for peroral delivery of bioactives

Microemulsions for oral delivery of insulin: Design, development and evaluation in streptozotocin induced diabetic rats

Nanoparticles made of multi-block copolymer of lactic acid and ethylene glycol containing periodic side-chain carboxyl groups for oral delivery of cyclosporine A

Preparation, characterization and in silico modeling of biodegradable nanoparticles containing cyclosporine A and coenzyme Q10

Biodegradable Nanoparticles Improve Oral Bioavailability of Amphotericin B and Show Reduced Nephrotoxicity Compared to Intravenous FungizoneA (R)

Current approaches to stabilising and analysing proteins during microencapsulation in PLGA

Design of Biodegradable Nanoparticles for Oral Delivery of Doxorubicin: In vivo Pharmacokinetics and Toxicity Studies in Rats

High-performance liquid chromatographic analysis of amphotericin B in rat plasma using alpha-naphthol as an internal standard

Impact of Polymeric Nanoparticles on Oral Pharmacokinetics: A Dose-Dependent Case Study with Estradiol

Multiblock Copolymers of Lactic Acid and Ethylene Glycol Containing Periodic Side-Chain Carboxyl Groups: Synthesis, Characterization, and Nanoparticle Preparation

Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer

Pharmacodynamic Evaluation of Oral Estradiol Nanoparticles in Estrogen Deficient (Ovariectomized) High-Fat Diet Induced Hyperlipidemic Rat Model

PLGA Nanoparticles Stabilized with Cationic Surfactant: Safety Studies and Application in Oral Delivery of Paclitaxel to Treat Chemical-Induced Breast Cancer in Rat

The Co-Encapsulated Antioxidant Nanoparticles of Ellagic Acid and Coenzyme Q(10) Ameliorates Hyperlipidemia in High Fat Diet Fed Rats

A potential therapeutic strategy for diabetes and its complications in the form of co-encapsulated antioxidant nanoparticles (NanoCAPs) of ellagic acid and coenzyme Q(10): Preparation and evaluation in streptozotocin induced diabetic rats

Nanoparticles Enhance Per Oral Bioavailability of Poorly Available Molecules: Epigallocatechin Gallate Nanoparticles Ameliorates Cyclosporine Induced Nephrotoxicity in Rats at Three Times Lower Dose Than Oral Solution

Oral nanoparticulate atorvastatin calcium is more efficient and safe in comparison to Lipicure((R)) in treating hyperlipidemia

PLGA nanoparticles for oral delivery of hydrophobic drugs: Influence of organic solvent on nanoparticle formation and release Behavior in vitro and in vivo using estradiol as a model drug

Biodegradable in situ gelling system for subcutaneous administration of ellagic acid and ellagic acid loaded nanoparticles: Evaluation of their antioxidant potential against cyclosporine induced nephrotoxicity in rats

Design and evaluation of biodegradable, biosensitive in situ gelling system for pulsatile delivery of insulin

Development of biodegradable nanoparticles for oral delivery of ellagic acid and evaluation of their antioxidant efficacy against cyclosporine A-induced nephrotoxicity in rats

Estradiol loaded PLGA nanoparticles for oral administration: Effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo

Nanotechnology in advanced drug delivery

PLGA nanoparticles for oral delivery of cyclosporine: Nephrotoxicity and pharmacokinetic studies in comparison to Sandimmune Neoral (R)

A special issue on Nanotechnology in advanced drug delivery

Peer review (28 reviews for 9 publications/grants)